Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
ELISA Kit for Periostin (POSTN)
OSF-2; PDLPOSTN; PN; Osteoblast Specific Factor 2
- Product No.SEH339Hu
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Sample Typeserum, plasma and other biological fluids
- Test MethodDouble-antibody Sandwich
- Assay Length3h
- Detection Range78-5,000pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 33pg/mL.
- DownloadInstruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
- FOB
US$ 490
For more details, please contact local distributors! US$ 700 US$ 3150 US$ 5950 US$ 49000
Specificity
This assay has high sensitivity and excellent specificity for detection of Periostin (POSTN).
No significant cross-reactivity or interference between Periostin (POSTN) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Periostin (POSTN) and the recovery rates were calculated by comparing the measured value to the expected amount of Periostin (POSTN) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 98-105 | 101 |
EDTA plasma(n=5) | 80-89 | 85 |
heparin plasma(n=5) | 81-101 | 89 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Periostin (POSTN) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Periostin (POSTN) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Periostin (POSTN) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 89-104% | 98-105% | 98-105% | 93-104% |
EDTA plasma(n=5) | 79-93% | 98-105% | 97-105% | 86-101% |
heparin plasma(n=5) | 94-102% | 87-98% | 88-96% | 79-98% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
Standard | 2 | Standard Diluent | 1×20mL |
Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
Detection Reagent B | 1×120µL | Assay Diluent B | 1×12mL |
TMB Substrate | 1×9mL | Stop Solution | 1×6mL |
Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.
GIVEAWAYS
INCREMENT SERVICES
- Single-component Reagents of Assay Kit
- Lysis Buffer Specific for ELISA / CLIA
- Quality Control of Kit
- ELISA Kit Customized Service
- Disease Model Customized Service
- Serums Customized Service
- TGFB1 Activation Reagent
- Real Time PCR Experimental Service
- Streptavidin
- Fast blue Protein Stain solution
- Single-component Reagents of FLIA Kit
- Streptavidin-Agarose Beads
Magazine | Citations |
Blood | Circulating Periostin Is Elevated In Patients With Hemoglobinopathies and Correlates With Bone Mineral Density In Double Heterozygous Sickle-Cell/Beta-Thalassemia Patients; A Novel Marker Of Bone Strength? Bloodjournal: Source |
The Journal of Clinical Endocrinology & Metabolism | Serum periostin is associated with fracture risk in postmenopausal women: a 7 years prospective analysis of the OFELY study Pubmed: 24628551 |
J Clin Endocrinol Metab. | Serum Periostin Is Associated With Fracture Risk in Postmenopausal Women: A 7-Year Prospective Analysis of the OFELY Study Pubmed:24628551 |
Rheumatology (Oxford). | Circulating periostin levels in patients with AS: association with clinical and radiographic variables, inflammatory markers and molecules involved in bone formation Pubmed:25349442 |
Journal of Periodontal Research | Assessment of periostin levels in serum and gingival crevicular fluid of patients with periodontal disease Pubmed:25529858 |
新医学 | 血清内脂素水平与多囊卵巢综合征的相关性研究 Xinyixue:Source |
Osteoarthritis | Serum periostin is associated with prevalent knee osteoarthritis and disease incidence/progression in women: the OFELY study PubMed: 26072384 |
Endocrine | Serum periostin is a potential biomarker for non-alcoholic fatty liver disease: a case– control study PubMed: 26362060 |
Blood Cancer Journal | High levels of periostin correlate with increased fracture rate, diffuse MRI pattern, abnormal bone remodeling and advanced disease stage in patients with newly … pubmed:27716740 |
Metabolism. | Low periostin levels in adult patients with Langerhans cell histiocytosis are independently associated with the disease activity. pubmed:28521873 |
Osteoporosis International | Circulating periostin levels increase in association with bone density loss and healing progression during the early phase of hip fracture in Chinese older women pubmed:28382553 |
Molecular Diagnosis & Therapy | The Utility of Biomarkers in Osteoporosis Management pubmed:28271451 |
Journal of Bone and Mineral Research | Cortical and trabecular bone microstructure did not recover at weight-bearing skeletal sites and progressively deteriorated at non-weight-bearing sites during the year following International Space Station missions doi:10.1002 |
Clinical Cases in Mineral and Bone Metabolism | Periostin and sclerostin levels in juvenile Paget's disease pubmed:29263750 |
Calcified Tissue International | Development of a New Immunoassay for Human Cathepsin K-Generated Periostin Fragments as a Serum Biomarker for Cortical Bone pubmed:28725907 |
Wiley | Characterization of a sandwich ELISA for the quantification of all human periostin isoforms pubmed:28493527 |
International Osteoporosis Foundation and National Osteoporosis Foundation | Interaction between LRP5 and periostin gene polymorphisms on serum periostin levels and cortical bone microstructure pubmed:29038835 |
Bone | Effect of age and gender on serum periostin: Relationship to cortical measures, bone turnover and hormones pubmed:28323143 |
Clinica Chimica Acta | Association between serum periostin concentrations and outcome after acute spontaneous intracerebral hemorrhage pubmed:28882488 |
Clinica Chimica Acta | Serum periostin concentrations and outcomes after severe traumatic brain injury pubmed:28668564 |
Tumor Biology | Predictive and prognostic value of serum periostin in advanced non–small cell lung cancer patients receiving chemotherapy pubmed:28459197 |
Journal of Bone and Mineral Research | Serum Levels of a Cathepsin-K Generated Periostin Fragment Predict Incident Low-Trauma Fractures in Postmenopausal Women Independently of BMD and FRAX pubmed:28766739 |
ОСОБЕННОСТИ СОСТОЯНИЯ ЗДОРОВЬЯ НОВОРОЖДЕННЫХ, РОЖДЕННЫХ ОТ МАТЕРЕЙ С БРОНХИАЛЬНОЙ АСТМОЙ 2017; 62:(4) | |
Endocrine | Circulating periostin in patients with nonalcoholic fatty liver disease. pubmed:27738886 |
Molecular Medicine Reports | Periostin cross‑reacts with the renin‑angiotensin system during liver fibrosis development pubmed:28849131 |
The Journal of Biological Chemistry | Toll-like receptor 2 deficiency hyperactivates the FoxO1 transcription factor and induces aging-associated cardiac dysfunction in mice Pubmed:29929978 |
Calcified Tissue International | The C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone Metastasis Pubmed:29916127 |
Journal of Endocrinological Investigation | Increased serum periostin concentrations are associated with the presence of diabetic retinopathy in patients with type 2 diabetes mellitus Pubmed:29349642 |
Wiener klinische Wochenschrift | Rheumatoid arthritis in remission |
Clinical and Experimental Medicine | Myostatin and other musculoskeletal markers in lung transplant recipients Pubmed: 30317402 |
Experimental and Clinical Endocrinology & Diabetes | Polycystic Ovary Syndrome is Associated with Elevated Periostin Levels Pubmed: 30372763 |
ИСПОЛЬЗОВАНИЕ СЫВОРОТОЧНОГО ПЕРИОСТИНА В КАЧЕСТВЕ МАРКЕРА ОБОСТРЕНИЙ АСТМЫ У ДЕТЕЙ | |
Bone | Tartrate-resistant acid phosphatase 5b, but not periostin, is useful for assessing Paget's disease of bone Pubmed: 31051316 |
Journal of Clinical Laboratory Analysis | Identification and diagnostic value of pleural fluid periostin and serum periostin of malignant pleural effusions in patients with non–small‐cell lung cancer Pubmed: 31268191 |
Bone | Serum periostin is associated with cancer mortality but not cancer risk in older home-dwelling men: A 8-year prospective analysis of the STRAMBO study Pubmed: 31812700 |
FASEB J | Fibronectin rescues aberrant phenotype of endothelial cells lacking either CCM1, CCM2 or CCM3 Pubmed: 32515053 |
Journal of Reproductive Immunology | Serum and placental periostin levels in women with early pregnancy loss Pubmed: 32460058 |
Annals of Medical Research | Evaluation of periostin levels in gingival crevicular fluid and peri-implant sulcus fluid in patients with periodontal and peri-implanter disease: A cross-sectional … |
Myostatin and Markers of Bone Metabolism in Dermatomyositis | |
Am J Physiol Heart Circ Physiol | Periostin promotes arterial calcification through PPAR¦Ã-related glucose metabolism reprogramming 33834866 |
International Journal of Chronic Obstructive Pulmonary Disease | High Blood Eosinophil and YKL-40 Levels, as Well as Low CXCL9 Levels, are Associated with Increased Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease 33814903 |
J Bone Oncol | Serum total periostin is an independent marker of overall survival in bone metastases of lung adenocarcinoma 34150488 |
Rambam Maimonides Med J | The Relationship between Serum Periostin Levels and Neutrophil¨CLymphocyte Ratio with Lesion Localization and Acute Prognosis in Acute Ischemic Stroke 34137680 |
Rambam Maimonides Medical Journal | First Admission Neutrophil–Lymphocyte Ratio May Indicate Acute Prognosis of Ischemic Stroke 34137680 |
Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
RPH339Hu03 | Recombinant Periostin (POSTN) | Positive Control; Immunogen; SDS-PAGE; WB. |
RPH339Hu01 | Recombinant Periostin (POSTN) | Positive Control; Immunogen; SDS-PAGE; WB. |
RPH339Hu02 | Recombinant Periostin (POSTN) | Positive Control; Immunogen; SDS-PAGE; WB. |
PAH339Hu01 | Polyclonal Antibody to Periostin (POSTN) | WB; IHC; ICC; IP. |
PAH339Hu02 | Polyclonal Antibody to Periostin (POSTN) | WB; IHC; ICC; IP. |
PAH339Hu03 | Polyclonal Antibody to Periostin (POSTN) | WB; IHC; ICC; IP. |
LAH339Hu71 | Biotin-Linked Polyclonal Antibody to Periostin (POSTN) | WB; IHC; ICC. |
MAH339Hu23 | Monoclonal Antibody to Periostin (POSTN) | WB; IHC; ICC; IP. |
MAH339Hu24 | Monoclonal Antibody to Periostin (POSTN) | WB |
MAH339Hu21 | Monoclonal Antibody to Periostin (POSTN) | WB; ICC/IF. |
MAH339Hu27 | Monoclonal Antibody to Periostin (POSTN) | WB; IHC; ICC; IP. |
MAH339Hu29 | Monoclonal Antibody to Periostin (POSTN) | WB; IHC; ICC; IP. |
MAH339Hu22 | Monoclonal Antibody to Periostin (POSTN) | WB; ICC/IF |
SEH339Hu | ELISA Kit for Periostin (POSTN) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMH339Hu | Multiplex Assay Kit for Periostin (POSTN) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |